Cook, Rachel J.

S248: SIERRA TRIAL RESULTS WITH A TARGETED RADIOTHERAPY, IOMAB-B, A MYELOABLATIVE CONDITIONING WITH REDUCED INTENSITY TOLERABILITY YIELDS HIGH CR, LONG TERM SURVIVAL IN HSCT INELIGIBLE ACTIVE R/R AML

Seropian, Stuart , Choe, Hannah , Litzow, Mark R. , Abboud, Camille N. , Koshy, Nebu , Stiff, Patrick J. , Tomlinson, Benjamin , Abhyankar, Sunil , Foran, James M. , Al‐Kadhimi, Zaid , Orozco, Johnnie J. , Jamieson, Katarzyna , Silverman, Margarida, Munshi, Pashna N. , Cook, Rachel J. , Mayer, Sebastian , Levy, Moshe , Reddy, Vijay , Spross, Jennifer , McNamara, Kathleen , Haeuber, Elaina, Vusirikala, Madhuri , Nahar, Akash, Pagel, John M. , Desai, Avinash, Nath, Rajneesh , Larkin, Karilyn , Gyurkocza, Boglarka , Hari, Parameswaran , Chen, George L. , Kebriaei, Partow , Sabloff, Mitchell , Besien, Koen van , Schuster, Michael K. , Law, Arjun , Abedin, Sameem , Rowley, Scott D , Lazarus, Hillard M. , Sandmaier, Brenda M , Mcnamara, Kathleen, Giralt, Sergio , Desai, Avinash

HemaSphere | August 21, 2023 | Volume: 7 | Issue: S3 | Pages: e2941723

10.1097/01.hs9.0000967904.29417.23